Trial Profile
Phase II, Randomized, Placebo-Controlled Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Finasteride (Primary)
- Indications Central serous chorioretinopathy
- Focus Therapeutic Use
- 24 Apr 2015 New trial record